Novel application of proteinchip technology exploring acute rejection markers of rat small bowel transplantation

Transplantation

Volumn 82, Issue 3, 2006, Pages 320-326

  Yamayoshi, Yasuko ^a   Watanabe, Toshihiko ^a   Tanabe, Minoru ^a   Hoshino, Ken ^a   Matsumoto, Koshi ^b   Morikawa, Yasuhide ^a   Shimadzu, Motohide ^a   Kitajima, Masaki ^a   Tanigawara, Yusuke ^a  

^a KEIO UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

Author keywords

Acute rejection; Biomarker; Lysozyme; SELDI TOF MS; Small bowel transplantation

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; LYSOZYME; MIGRATION INHIBITION FACTOR; MIGRATION INHIBITION FACTOR RELATED PROTEIN; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; GRAFT REJECTION; HETEROTOPIC TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTESTINE TRANSPLANTATION; ISOTRANSPLANTATION; LAMINA PROPRIA; MACROPHAGE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN MICROARRAY; PROTEOMICS; RAT; RETENTATE CHROMATOGRAPHY MASS SPECTROMETRY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; DISEASE MODELS, ANIMAL; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; INTESTINE, SMALL; MALE; MOLECULAR SEQUENCE DATA; MURAMIDASE; PROTEIN ARRAY ANALYSIS; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 33747102408     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000228909.49640.08     Document Type: Article

References (28)

1. Todo S, Reyes J, Furukawa H, et al. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995; 222: 270.
2. Kato T, Gaynor JJ, Selvaggi G, et al. Intestinal transplantation in children: a summary of clinical outcomes and prognostic factors in 108 patients from a single center. J Gastrointest Surg 2005; 9: 75.
3. Goulet O, Lacaille F, Jan D, Ricour C. Intestinal transplantation: indications, results and strategy. Curr Opin Clin Nutr Metab Care 2000; 3: 329.
4. Sigurdsson L, Reyes J, Putnam PE, et al. Endoscopies in pediatric small intestinal transplant recipients: five years experience. Am J Gastroenterol 1998; 93: 207.
5. Kato T, O'Brien CB, Berho M, et al. Improved rejection surveillance in intestinal transplant recipients with frequent use of zoom video endoscopy. Transplant Proc 2000; 32: 1200.
6. Quan D, Grant DR, Zhong RZ, et al. Altered gene expression of cytokine, ICAM-1, and class II molecules precedes mouse intestinal allograft rejection. Transplantation 1994; 58: 808.
7. Miyagi K, Kiyochi H, Honda K, Kobayashi K. Serum and bile individual bile acid changes as a noninvasive marker of small bowel allograft rejection in rats. Transplant Proc 2000; 32: 1265.
8. Pappas PA, Saudubray JM, Tzakis AG, et al. Serum citrulline and rejection in small bowel transplantation: a preliminary report. Transplantation 2001; 72: 1212.
9. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572.
10. Qu Y, Adam BL, Yasui Y, et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem 2002; 48: 1835.
11. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000; 21: 1164.
12. Monchik GJ, Russell PS. Transplantation of small bowel in the rat: technical and immunological considerations. Surgery 1971; 70: 693.
13. Weinberger SR, Boschetti E, Santambien P, Brenac V. Surface-enhanced laser desorption-ionization retentate chromatography mass spectrometry (SELDI-RC-MS): a new method for rapid development of process chromatography conditions. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 782: 307.
14. Todo S, Tzakis AG, Abu-Elmagd K, et al. Intestinal transplantation in composite visceral grafts or alone. Ann Surg 1992; 216: 223.
15. Clarke W, Silverman BC, Zhang Z, et al. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 2003; 237: 660.
16. Schaub S, Rush D, Wilkins J, et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 2004; 15: 219.
17. Ikemoto M, Tanaka T, Takai Y, et al. New ELISA system for myeloid-related protein complex (MRP8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clin Chem 2003; 49: 594.
18. Kato T, Berho M, Weppler D, et al. Is severe rejection an indication for retransplantation? Transplant Proc 2000; 32: 1201.
19. Johne B, Fagerhol MK, Lyberg T, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997; 50: 113.
20. Mason DY, Taylor CR. The distribution of muramidase (lysozyme) in human tissues. J Clin Pathol 1975; 28: 124.
21. Orloff SL, Yin Q, Corless CL, et al. A rat small bowel transplant model of chronic rejection: histopathologic characteristics. Transplantation 1999; 68: 766.
22. Fryer J, Grant D, Jiang J, et al. Influence of macrophage depletion on bacterial translocation and rejection in small bowel transplantation. Transplantation 1996; 62: 553.
23. McClelland DB, van Furth R. In vitro synthesis of lysozyme by human and mouse tissues and leucocytes. Immunology 1975; 28: 1099.
24. Lewis CE, McCarthy SP, Lorenzen J, McGee JO. Differential effects of LPS, IFN-gamma and TNF alpha on the secretion of lysozyme by individual human mononuclear phagocytes: relationship to cell maturity. Immunology 1990; 69: 402.
25. Stamp GW, Poulsom R, Chung LP, et al. Lysozyme gene expression in inflammatory bowel disease. Gastroenterology 1992; 103: 532.
26. Zwadlo G, Bruggen J, Gerhards G, et al. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin Exp Immunol 1988; 72: 510.
27. Grimm PC, McKenna R, Nickerson P, et al. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol 1999; 10: 1582.
28. Russell ME, Wallace AF, Hancock WW, et al. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 1995; 59: 572.